Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Median Effective Dose of Remifentanil for the Prevention of Pain Caused by the Injection of Rocuronium

NCT05217238 is registered in ClinicalTrials.gov with Yangzhou University as lead sponsor.

NCT NCT05217238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05217238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Median Effective Dose of Remifentanil for the Prevention of Pain Caused by the Injection of Rocuronium
Lead sponsor
Yangzhou University
Phase
Not applicable
Overall status
Unknown status
Start date
December 18, 2021
Completion date
March 30, 2022
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

injection pain, rocuronium